DTIL
DTIL
NASDAQ · Biotechnology

Precision Biosciences Inc

$7.69
+0.21 (+2.81%)
As of May 16, 2:14 AM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +299.1% upside
Low Target $21.79
Average Target $30.69
High Target $37.55
Current Price $7.69
Current
$7.69
Target
$30.69
$21.79 $30.69 avg $37.55
Scenario Analysis
Bear Case
$21.79
183.4%
Low target
Base Case
$30.69
+299.1%
Avg target
Bull Case
$37.55
+388.3%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$8.82
-12.8% from high
52-Week Low
$3.53
+117.8% from low
Target vs 52W High
$30.69
+248.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
Buy 43 56% $91.45 -52.6%